Whether or not Sycamore can fix the problems with Walgreens, it is likely to do well in the deal, considering it is getting the chain at a fraction of its former value and because of the way the deals ...

The ultimate victor from the deal may be neither the Walgreens executives nor Sycamore, but Walgreens bondholders. It has ...

US pharmacy giant Walgreens Boots Alliance is going private. Will the new owners sell off the high-street chemist?

Sycamore’s deal to take Walgreens private follows the storied chain’s decline amid e-commerce and health-industry changes.

Walgreens Boots Alliance is being acquired by a private-equity firm for about $10 billion, the retail pharmacy giant announced Thursday. An entity affiliated with Sycamore Partners will acquire ...

While financial and retail analysts continue to evaluate the implications of Walgreens Boots Alliance’s recent agreement to ...

It marks the end of an 11-year dispute that started when two whistleblowers claimed Walgreens’ practices violated the False ...

Walgreens has been attempting a financial ... and would be sold to Sycamore Partners, a private equity firm. Less than a decade ago it was America’s largest drugstore chain, and its stock ...

Walgreens said Thursday that Sycamore will pay $11.45 per share, giving the deal an equity value just under $10 billion. Shareholders could eventually receive up to another $3 per share under certain ...

Roula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter. Walgreens Boots Alliance has struck a deal worth up to $23.7bn with private equity group Sycamore Partners ...